$12.16 Billion in Sales Expected for HCA Healthcare Inc (HCA) This Quarter

Share on StockTwits

Equities research analysts expect HCA Healthcare Inc (NYSE:HCA) to announce $12.16 billion in sales for the current quarter, Zacks Investment Research reports. Ten analysts have issued estimates for HCA Healthcare’s earnings, with the highest sales estimate coming in at $12.35 billion and the lowest estimate coming in at $12.04 billion. HCA Healthcare reported sales of $11.56 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 5.2%. The company is scheduled to announce its next earnings results on Tuesday, January 29th.

According to Zacks, analysts expect that HCA Healthcare will report full year sales of $46.53 billion for the current financial year, with estimates ranging from $46.20 billion to $46.76 billion. For the next fiscal year, analysts anticipate that the business will report sales of $49.52 billion, with estimates ranging from $48.59 billion to $50.67 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for HCA Healthcare.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The business had revenue of $11.45 billion for the quarter, compared to analyst estimates of $11.29 billion. During the same period in the prior year, the firm posted $1.13 EPS. The company’s revenue was up 7.1% on a year-over-year basis.

HCA has been the subject of a number of research reports. Jefferies Financial Group raised their price objective on HCA Healthcare to $155.00 and gave the stock a “buy” rating in a research report on Friday, September 21st. Leerink Swann lifted their price target on HCA Healthcare from $140.00 to $150.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 4th. Mizuho set a $150.00 price objective on HCA Healthcare and gave the company a “buy” rating in a research report on Tuesday, September 4th. Argus boosted their price target on HCA Healthcare to $150.00 and gave the company a “buy” rating in a research note on Friday, September 7th. Finally, Bank of America boosted their price objective on HCA Healthcare from $125.00 to $135.00 and gave the stock an “underperform” rating in a research note on Tuesday, September 18th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $144.15.

HCA stock traded down $4.99 during mid-day trading on Wednesday, reaching $135.86. The company had a trading volume of 1,801,284 shares, compared to its average volume of 1,788,475. The stock has a market capitalization of $48.48 billion, a price-to-earnings ratio of 20.62, a PEG ratio of 1.24 and a beta of 0.52. HCA Healthcare has a one year low of $84.13 and a one year high of $147.42.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be paid a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date of this dividend is Friday, November 30th. HCA Healthcare’s dividend payout ratio is 21.24%.

In other HCA Healthcare news, SVP Deborah M. Reiner sold 723 shares of HCA Healthcare stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $135.06, for a total value of $97,648.38. Following the completion of the sale, the senior vice president now owns 6,184 shares of the company’s stock, valued at approximately $835,211.04. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Kathryn A. Torres sold 820 shares of HCA Healthcare stock in a transaction on Tuesday, November 13th. The stock was sold at an average price of $142.36, for a total transaction of $116,735.20. Following the transaction, the senior vice president now owns 4,237 shares in the company, valued at approximately $603,179.32. The disclosure for this sale can be found here. Insiders have sold 16,763 shares of company stock valued at $2,346,147 in the last three months. 2.80% of the stock is owned by insiders.

Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its position in HCA Healthcare by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 19,916,360 shares of the company’s stock valued at $2,770,765,000 after buying an additional 66,808 shares during the period. FMR LLC increased its stake in HCA Healthcare by 98.7% during the 3rd quarter. FMR LLC now owns 10,907,407 shares of the company’s stock valued at $1,517,438,000 after purchasing an additional 5,419,134 shares in the last quarter. LSV Asset Management increased its stake in shares of HCA Healthcare by 0.3% in the third quarter. LSV Asset Management now owns 5,474,392 shares of the company’s stock worth $761,597,000 after acquiring an additional 15,004 shares during the period. Lyrical Asset Management LP increased its stake in shares of HCA Healthcare by 2.0% in the third quarter. Lyrical Asset Management LP now owns 4,078,212 shares of the company’s stock worth $567,361,000 after acquiring an additional 80,081 shares during the period. Finally, Northern Trust Corp grew its position in HCA Healthcare by 4.2% during the second quarter. Northern Trust Corp now owns 3,460,267 shares of the company’s stock valued at $355,023,000 after buying an additional 138,135 shares during the period. Institutional investors and hedge funds own 69.94% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Derivative

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Marshall Wace North America L.P. Takes $14.70 Million Position in Transocean LTD
Marshall Wace North America L.P. Takes $14.70 Million Position in Transocean LTD
$12.16 Billion in Sales Expected for HCA Healthcare Inc  This Quarter
$12.16 Billion in Sales Expected for HCA Healthcare Inc This Quarter
Wedbush Securities Inc. Has $620,000 Holdings in Williams Companies Inc
Wedbush Securities Inc. Has $620,000 Holdings in Williams Companies Inc
Wedbush Securities Inc. Cuts Holdings in Johnson Controls International PLC
Wedbush Securities Inc. Cuts Holdings in Johnson Controls International PLC
Wedbush Securities Inc. Grows Holdings in Sabra Health Care REIT Inc
Wedbush Securities Inc. Grows Holdings in Sabra Health Care REIT Inc
Powell Industries  Receiving Somewhat Critical Press Coverage, Analysis Shows
Powell Industries Receiving Somewhat Critical Press Coverage, Analysis Shows


Leave a Reply

© 2006-2018 Ticker Report